SCHEMBL21935667

SCHEMBL21935667

COc1ccc(Cc2cc(C(=O)NC3CCCCC3)nc3c2OCC3)cc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SMN1; SMN2 Q16637 2/20 0.48
▸ KMT2A Q03164 2/20 0.48
▸ TP53 P04637 1/20 0.48
▸ THRB P10828 1/20 0.48
▸ NPC1 O15118 4/20 0.48
▸ RAB9A P51151 4/20 0.48
▸ EPHX2 P34913 1/20 0.47
▸ ALDH1A1 P00352 3/20 0.47
▸ CNR1 P21554 4/20 0.47
▸ CNR2 P34972 4/20 0.46
▸ ABHD6 Q9BV23 1/20 0.46
▸ HPGD P15428 3/20 0.45
▸ KDM4E B2RXH2 2/20 0.45
▸ HSD17B10 Q99714 2/20 0.45
▸ MAOA P21397 1/20 0.45
▸ MAOB P27338 1/20 0.45
▸ CYP1A2 P05177 1/20 0.44
▸ CYP3A4 P08684 1/20 0.44
▸ CYP2D6 P10635 1/20 0.44
▸ CYP2C9 P11712 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30428181 0.88 CHRM1 (0.47) CNR1
SCHEMBL21873411 0.88 CHRM1 (0.47) CNR1
SCHEMBL22212650 0.88 NPC1 (0.49) SMN1; SMN2KMT2ATP53THRBNPC1
SCHEMBL21935658 0.88 ADORA2A (0.42) SMN1; SMN2KMT2ATP53THRBCNR1
SCHEMBL31668971 0.87 CHRM1 (0.46) CNR1
SCHEMBL21873468 0.87 CHRM1 (0.46) CNR1
SCHEMBL21935399 0.86 ADORA2A (0.43) NPC1RAB9AALDH1A1CNR1CNR2
SCHEMBL19932685 0.84 NPC1 (0.46) SMN1; SMN2KMT2ATP53THRBNPC1
SCHEMBL21873488 0.83 SLC5A1 (0.39) SMN1; SMN2RAB9AALDH1A1KDM4ECYP1A2
SCHEMBL30429049 0.83 SLC5A1 (0.39) SMN1; SMN2RAB9AALDH1A1KDM4ECYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3643718-B1 HETEROCYCLIC COMPOUND AND ITS USE AS POSITIVE ALLOSTERIC MODULATOR OF THE CHOLINERGIC MUSCARINIC M1 RECEPTOR. TAKEDA PHARMACEUTICALS CO (JP) 2023-07-26 — — EP disclosed
EP-3643718-A1 HETEROCYCLIC COMPOUND Takeda Pharmaceutical Company Limited (JP) 2020-04-29 — — EP disclosed
Send feedback